Nanomedicine News

RSS

Alnylam Starts Phase I Clinical Trial of Lipid Nanoparticle-Based ALN-TTR02

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has begun the Phase I clinical trial of ALN-TTR02, which uses the company’s in-house second-generation lipid nanoparticle technology utilizing the MC3 lipid.

21 Mar 2012

Researchers Use Bacteria Inclusion Bodies as Natural Nanopills

Researchers from the Universitat Autònoma de Barcelona (UAB) have designed a novel carrier called as ‘bacteria inclusion bodies’ to deliver proteins with therapeutic effects.

19 Mar 2012

Chitosan Nanoparticles for Wound Healing and Anti-Aging Applications

A research team comprising Mihaela Leonida and colleagues from the Fairleigh Dickinson University has reported a process for producing chitosan nanoparticles in the International Journal of Nano and Biomaterials.

19 Mar 2012

Nanotechnology for Treating Cancer

Professor Mark Davis from the California Institute of Technology believes that nanotechnology is capable of revolutionizing the way of diagnosing, monitoring and treating cancer.

17 Mar 2012

Silver Nanoparticles Affect Testicular Cells

The Norwegian Institute of Public Health recently conducted a study to determine the effect of silver and titanium dioxide nanoparticles on testicular cells. They found that titanium dioxide nanoparticles caused comparatively lesser damage than silver nanoparticles.

15 Mar 2012

Researcher Investigates Nanoparticles to Destroy Tumors Non-Invasively

Professor Sotiris E. Pratsinis from the ETH Zurich, Switzerland, has been a visiting scientist at the Universität Duisburg-Essen (UDE) since January 2012 and carries out fundamental research on nanoparticles.

15 Mar 2012

Research and Markets Offers Report on Nanodiagnostics Market

Research and Markets has included a new report titled ‘Nanotechnology for Medical Diagnostics’ from Cientifica to its database.

From Research and Markets 15 Mar 2012

Silver Nanoparticles Help Cure Hard-to-Treat Mouth Infections

Researchers have discovered that silver nanoparticles can be used to destroy yeasts such as Candida glabrata and Candida albicans, which cause difficult-to-treat mouth infections.

9 Mar 2012

Study Discovers Primary Target of Thalidomide Teratogenicity Using Magnetic Nanobeads

A research team comprising Hiroshi Handa and his colleagues from the Tokyo Institute of Technology has determined an important protein called cereblon utilizing novel sub-micrometer functionalized magnetic nanobeads developed at the institute.

6 Mar 2012

Vascular Magnetics Receives Financing to Develop Magnetically Targeted Nanoparticle-Based Drug Delivery

The Children's Hospital of Philadelphia’s spin-out start-up company, Vascular Magnetics has amassed $7 million to develop a novel drug delivery system called vascular magnetic intervention utilizing magnetically targeted nanoparticles for the treatment of peripheral artery disease.

3 Mar 2012